Renew Biopharma and Algae-C Announce License Agreement for Best-in-Class Engineered Enzymes
SAN DIEGO–(BUSINESS WIRE)–Renew Biopharma (“Renew”) announced today that Algae-C Inc. (“Algae-C”) has licensed rights to employ Renew’s proprietary engineered enzymes for use toward biosynthesis of cannabinoids in microalgae. Renew’s portfolio of engineered enzymes are designed to support enhanced production of cannabinoids and cannabinoid derivatives. While Renew has employed these enzymes towards the company’s neurotherapeutic drug…
Details